Manning Mark, O'Neill Suzanne, Purrington Kristen
Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Breast J. 2021 Jul;27(7):586-594. doi: 10.1111/tbj.14240. Epub 2021 May 14.
Breast density notification laws have been adopted in the absence of consistent guidelines for post-notification follow-up. This can lead to inconsistent and potentially deficient management of women's health due to inconsistent physician practices. We examined physicians' knowledge and practices regarding follow-up for patients who receive density notifications. Physicians who referred patients to a Michigan hospital network for screening mammograms were recruited to participate in survey study; 105 (29.8%) responded. The survey assessed physicians' demographics, knowledge, and awareness of breast density and breast cancer risk and of density notification laws, and perceptions of appropriate follow-up behaviors for their patients who received density notifications. Most physicians (75%) knew about the notification law, and they were generally comfortable responding to breast density questions and deciding on follow-up. Most indicated that additional breast imaging (68.0%), followed by assessing breast cancer risk (24.7%) were appropriate follow-up responses. Physicians who performed breast cancer risk assessments, and who were more comfortable with breast density questions and follow-up decision making, were more likely to propose additional imaging. Male physicians were less likely to propose assessing breast cancer risk, and less likely to propose clinical and/or breast self-examinations. Divergence between practice and guidelines when it comes to supplemental breast cancer screening, coupled with density notification language that promotes additional screening in the absence of consistent evidence, remains concerning. Improved understanding of how density notification recipients and their physicians make decisions about supplemental screening is warranted to ensure that breast cancer risk is properly considered.
在缺乏通知后后续跟进的统一指南的情况下,乳房密度通知法已被采用。由于医生的做法不一致,这可能导致对女性健康的管理不一致且可能存在缺陷。我们研究了医生对于收到密度通知的患者进行后续跟进的知识和做法。招募了将患者转诊至密歇根医院网络进行乳腺钼靶筛查的医生参与一项调查研究;105人(29.8%)做出了回应。该调查评估了医生的人口统计学特征、对乳房密度和乳腺癌风险以及密度通知法的了解和认识,以及他们对收到密度通知的患者适当后续行为的看法。大多数医生(75%)了解通知法,并且他们通常乐于回答有关乳房密度的问题并决定后续跟进措施。大多数人表示,额外的乳房成像检查(68.0%),其次是评估乳腺癌风险(24.7%)是适当的后续应对措施。进行乳腺癌风险评估、对乳房密度问题和后续决策更有信心的医生更有可能建议进行额外的成像检查。男性医生不太可能建议评估乳腺癌风险,也不太可能建议进行临床和/或乳房自我检查。在补充性乳腺癌筛查方面,实际做法与指南之间存在差异,再加上在缺乏一致证据的情况下促进额外筛查的密度通知措辞,仍然令人担忧。有必要更好地了解密度通知接收者及其医生如何就补充性筛查做出决策,以确保正确考虑乳腺癌风险。